Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Verbal learning and memory and psychopathology in schizophrenia.

Manglam MK, Das A.

Asian J Psychiatr. 2013 Oct;6(5):417-20. doi: 10.1016/j.ajp.2013.05.009.

PMID:
24011690
2.

Impairment of verbal memory and learning in antipsychotic-naïve patients with first-episode schizophrenia.

Hill SK, Beers SR, Kmiec JA, Keshavan MS, Sweeney JA.

Schizophr Res. 2004 Jun 1;68(2-3):127-36.

PMID:
15099597
3.

[Influence of attention on an auditory-verbal learning test in schizophrenic patients].

Huguelet P, Nicastro R, Zanello A.

Encephale. 2002 Jul-Aug;28(4):291-7. French.

PMID:
12232538
4.

Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia - An observational 9-year follow-up study.

Husa AP, Rannikko I, Moilanen J, Haapea M, Murray GK, Barnett J, Jones PB, Isohanni M, Koponen H, Miettunen J, Jääskeläinen E.

Schizophr Res. 2014 Sep;158(1-3):134-41. doi: 10.1016/j.schres.2014.06.035.

PMID:
25034761
5.

Serum testosterone levels are related to cognitive function in men with schizophrenia.

Moore L, Kyaw M, Vercammen A, Lenroot R, Kulkarni J, Curtis J, O'Donnell M, Carr VJ, Shannon Weickert C, Weickert TW.

Psychoneuroendocrinology. 2013 Sep;38(9):1717-28. doi: 10.1016/j.psyneuen.2013.02.007.

PMID:
23490072
6.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. French.

PMID:
19081451
7.

Electrophysiological basis for the ability of olanzapine to improve verbal memory and functional outcome in patients with schizophrenia: a LORETA analysis of P300.

Higuchi Y, Sumiyoshi T, Kawasaki Y, Matsui M, Arai H, Kurachi M.

Schizophr Res. 2008 Apr;101(1-3):320-30. doi: 10.1016/j.schres.2008.01.020.

PMID:
18321680
8.

Profiling cognitive impairment in treatment-resistant schizophrenia patients.

Frydecka D, Beszłej JA, Gościmski P, Kiejna A, Misiak B.

Psychiatry Res. 2016 Jan 30;235:133-8. doi: 10.1016/j.psychres.2015.11.028.

PMID:
26706131
9.

Selectivity of verbal memory deficit in schizophrenic patients and their relatives.

Toulopoulou T, Morris RG, Rabe-Hesketh S, Murray RM.

Am J Med Genet B Neuropsychiatr Genet. 2003 Jan 1;116B(1):1-7.

PMID:
12497605
10.

Profile of cognitive deficits and associations with depressive symptoms and intelligence in chronic early-onset schizophrenia patients.

Jepsen JR, Fagerlund B, Pagsberg AK, Christensen AM, Nordentoft M, Mortensen EL.

Scand J Psychol. 2013 Oct;54(5):363-70. doi: 10.1111/sjop.12062.

PMID:
23786210
11.

Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.

Rémillard S, Pourcher E, Cohen H.

J Int Neuropsychol Soc. 2008 Jan;14(1):110-8.

PMID:
18078537
12.

Verbal memory errors and symptoms in schizophrenia.

Heinrichs RW, Vaz SM.

Cogn Behav Neurol. 2004 Jun;17(2):98-101.

PMID:
15453518
13.

Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state.

Hurlemann R, Jessen F, Wagner M, Frommann I, Ruhrmann S, Brockhaus A, Picker H, Scheef L, Block W, Schild HH, Moller-Hartmann W, Krug B, Falkai P, Klosterkotter J, Maier W.

Psychol Med. 2008 Jun;38(6):843-51. doi: 10.1017/S0033291708003279.

PMID:
18387213
14.

Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications.

Lee J, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.

Schizophr Res. 2015 Apr;163(1-3):24-31. doi: 10.1016/j.schres.2014.08.014.

15.

Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.

de Bartolomeis A, Balletta R, Giordano S, Buonaguro EF, Latte G, Iasevoli F.

Psychiatry Res. 2013 Dec 15;210(2):387-95. doi: 10.1016/j.psychres.2013.06.042.

PMID:
23910239
16.

Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study.

Wobrock T, Falkai P, Schneider-Axmann T, Hasan A, Galderisi S, Davidson M, Kahn RS, Derks EM, Boter H, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, Gaebel W, Fleischhacker WW; EUFEST study group..

Schizophr Res. 2013 Jun;147(1):132-9. doi: 10.1016/j.schres.2013.03.001.

PMID:
23537477
17.

The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients.

Andersen R, Fagerlund B, Rasmussen H, Ebdrup BH, Aggernaes B, Gade A, Oranje B, Glenthoj B.

Eur Psychiatry. 2013 Aug;28(6):332-9. doi: 10.1016/j.eurpsy.2012.06.003.

PMID:
22999439
18.

Perospirone in the treatment of schizophrenia: effect on verbal memory organization.

Araki T, Yamasue H, Sumiyoshi T, Kuwabara H, Suga M, Iwanami A, Kato N, Kasai K.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Mar;30(2):204-8.

PMID:
16300872
19.

Improvement in verbal memory following SSRI augmentation of antipsychotic treatment is associated with changes in the expression of mRNA encoding for the GABA-A receptor and BDNF in PMC of schizophrenic patients.

Silver H, Mandiuk N, Einoch R, Susser E, Danovich L, Bilker W, Youdim M, Weinreb O.

Int Clin Psychopharmacol. 2015 May;30(3):158-66. doi: 10.1097/YIC.0000000000000070.

PMID:
25756551
20.

Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study.

Olivier MR, Killian S, Chiliza B, Asmal L, Schoeman R, Oosthuizen PP, Kidd M, Emsley R.

Psychol Med. 2015 Oct;45(13):2873-83. doi: 10.1017/S0033291715000860.

PMID:
25998030
Items per page

Supplemental Content

Support Center